-->

Company Registry

Abalone Bio Inc
Profile last edited on: 8/2/2019

Antibody therapeutics for cancer, inflammation, and pain
Year Founded
2017
First SBIR Year
2018
Latest SBIR Award
2022
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2600 Hilltop Drive Building B Room C332
Richmond, CA 94806
   (510) 288-8776
   N/A
   www.abalonebio.com
Multiple Locations:   
Congressional District:   11
County:   Contra Costa

Public Profile

Antibody therapeutics for cancer, inflammation, and pain. Abalone is shifting the paradigm for antibody development, isolating drug candidates directly by their modulating effects on integral membrane proteins. Its drug development programs address unmet needs in oncology, inflammation and pain sensation. Abalone is an early stage biotech start-up in the San Francisco Bay Area. It is partnering with leading academic labs, targeting G protein-coupled receptors (GPCRs) and ion channels.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Carlos Gustavo Pesce --

  Lauren J Schwimmer -- VP of Preclinical Development

  Richard Yu --

SBIR firms in the news

There are no news available.